informaSeq® Prenatal Test

CPT: 81420
Print Share

Test Details


  • Cell-free Fetal DNA Trisomy Testing


The informaSeq test is a prenatal aneuploidy assay used for screening chromosomes 13, 18, and 21. The X and Y chromosomes are not assessed by this assay. The test is validated for singleton and twin pregnancies with gestational ages of at least 10 weeks. This test is not intended to be used for fetal diagnostic purposes or as a stand-alone diagnostic test without confirmation by another medically established diagnostic product or procedure. Test results that suggest high risk for fetal trisomy should prompt consideration for genetic counseling. Results should be considered in the context of other clinical criteria.


Fetal aneuploidy for chromosomes 13, 18, and 21 is assessed in twin gestations; however, when detected, the individual aneuploidy status of each fetus cannot be determined. Sex chromosome aneuploidy is not assessed. In rare cases, the test results may reflect confined placental mosaicism or maternal aneuploidy, rather than the fetal status. A negative test result does not exclude aneuploidy of chromosomes 13, 18, 21, or the presence of other chromosome or fetal abnormalities. Correlation of these results with all clinical findings is recommended.

This test was developed, and the performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).


Cell-free DNA is isolated from the sample and analyzed using the next generation sequencing (NGS) platform.

Specimen Requirements


Whole blood


10 mL

Minimum Volume

7 mL


Black-and-tan-top (Streck) tube (whole blood). If needed, collection kits are available. (PeopleSoft N°107762)


Only the LabCorp informaSeq collection kit PeopleSoft N°107762 can be used for collection.

Storage Instructions

Maintain specimen at room temperature. Samples must be shipped to LabCorp in an informaSeq® collection kit with gel pack or, minimally, in the foil pack with gel pack available in the collection kit. Specimens should remain in the foil pack and collection kit during transport to the regional laboratory. Transport from the regional laboratory to CMBP may be effected in the foil pack with gel pack or a bulk shipper with gel pack

Causes for Rejection

Gestational age less than 10 weeks; expired or incorrect blood tubes (including nonglass tubes); quantity not sufficient for analysis; specimen received more than six days from collections; excessive hemolysis; frozen specimens; specimen received without foil pack and cold pack

Clinical Information

Special Instructions

The following information must be provided with the test request form: patient's date of birth, gestational age, and the clinical indications (including advanced maternal age, abnormal ultrasound, history suggestive of increased risk for aneuploidy, positive serum screen, or other indications). Additional patient demographic information (weight, race, pregnancy type, donor egg status) can be provided on the Maternal Prenatal Screening form (0900) or the electronic submission form.


Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012 May; 119(5):890-901. 22362253
Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn. 2013 Jun; 33(6):569-574. 23592485
Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med. 2013 May; 15(5):395-398. 23558255
Internal correlation data on file.
American College of Obstetricians and Gynecologists Committee on Genetics. Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion N° 545. Obstet Gynecol. 2012 Dec; 120(6):1532-1534. 23168792
Sehnert AJ, Rhees B, Comstock D, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem. 2011 Jul; 57(7):1042-1049. 21519036


Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
550746 informaSeq(R) Prenatal Test 511955 PDF 51969-4
550746 informaSeq(R) Prenatal Test 550717 Results 55228-1
550746 informaSeq(R) Prenatal Test 550718 Screen Result 75975-3
550746 informaSeq(R) Prenatal Test 550719 Chromosome 21 Result 75983-7
550746 informaSeq(R) Prenatal Test 550721 Chromosome 21 Interpretation 75976-1
550746 informaSeq(R) Prenatal Test 550722 Chromosome 18 Result 75982-9
550746 informaSeq(R) Prenatal Test 550726 Chromosome 18 Interpretation 75978-7
550746 informaSeq(R) Prenatal Test 550727 Chromosome 13 Result 75981-1
550746 informaSeq(R) Prenatal Test 550728 Chromosome 13 Interpretation 75979-5
550746 informaSeq(R) Prenatal Test 550733 Comments 8251-1
550746 informaSeq(R) Prenatal Test 550736 Fetal Number 11878-6
550746 informaSeq(R) Prenatal Test 550737 Gestational Age at Collection weeks 18185-9
550746 informaSeq(R) Prenatal Test 550738 Indication for Testing 42349-1
550746 informaSeq(R) Prenatal Test 550739 Race 21484-1
550746 informaSeq(R) Prenatal Test 550741 Weight lbs 29463-7
550746 informaSeq(R) Prenatal Test 550743 Test Description 49549-9
550746 informaSeq(R) Prenatal Test 550744 Disclaimer N/A
550746 informaSeq(R) Prenatal Test 550748 Test Limitations 8262-8
550746 informaSeq(R) Prenatal Test 550827 informaSeq(SM) Prenatal Test N/A
550746 informaSeq(R) Prenatal Test 550829 informaSeq(SM) Prenatal Test N/A
550746 informaSeq(R) Prenatal Test 550834 References 75608-0
550746 informaSeq(R) Prenatal Test 550838 Director Review 72486-4
550746 informaSeq(R) Prenatal Test 550844 Test Performance 74020-9
550746 informaSeq(R) Prenatal Test 550852 Fetal Fraction (%): 75605-6

For Providers

Please login to order a test.


© 2018  Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2018, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at Additional information regarding LOINC® codes can be found at, including the LOINC Manual, which can be downloaded at